The Department of Justice under Attorney General Jeff Sessions is forcing the Drug Enforcement Administration to backtrack on a new policy in which the DEA promised to issue more federal permits for scientific research into marijuana. The DEA’s move a year ago was hailed as a small step in the rightContinue Reading
At High Sobriety, an innovative addiction treatment center in Southern California, cannabis isn’t just tolerated—it’s provided as part of recovery. The post At This LA Rehab Center, Cannabis Is an ‘Exit’ Drug appeared first on Leafly. Read More: At This LA Rehab Center, Cannabis Is an ‘Exit’ DrugContinue Reading
New book from Ed Rosenthal and David Downs explores innovations in other agricultural industries and applies them to cannabis cultivation. Master cannabis cultivator Ed Rosenthal is in a state of constant experimentation. Within his office there is a blue jar with an electronic top measuring the precise humidity levels inside.Continue Reading
Aphria is increasing its stake in the booming cannabinoid-based extracts market with an 11.5 million Canadian dollar ($9 million) investment in Scientus Pharma, a vertically integrated biopharmaceutical company. Toronto-based Scientus Pharma conducts research and product development related to medical cannabinoids and their derivatives. The investment is in the form ofContinue Reading
A report about the “Trial of the plant” in South Africa, doctors for life, fabricated protesters and excellent testimony of key witness professor David Nutt. After seven years of preparing, the Trial of the Plant is on its way. Jules Stobbs and Myrtle Clarke are the driving force behind theContinue Reading
By Matt Lamers There’s no denying the massive potential of the global medical marijuana market: A recent report pegged it at 180 billion Canadian dollars ($142 billion) over the next 15 years. But going overseas is fraught with pitfalls, barriers and red tape. Canadian MMJ businesses, however, are export pioneersContinue Reading
By Bart Schaneman When Hawaii’s two operational medical marijuana dispensaries were forced to close just days after opening, a laboratory bottleneck was blamed for a supply disruption. But participants in the fledgling MMJ program said the state’s only functioning lab isn’t at fault. Instead, they pointed to a number ofContinue Reading
